arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Alphatec Holdings, Inc.

ATEC
$10.02 ▼ -0.31 (-3.00%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
68 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
20
Health
Poor
Bearish
auto_awesome

Analytical Summary

Alphatec Holdings, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.6B
Dividend Yield
Revenue Growth 15.1%
Op. Margin -0.9%
ROIC -0.3%
FCF / Share $0.00
Trailing P/E
Price / Book
FCF Yield 0.0%
Debt / Equity -53.09
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$213.51M
↑ +15.1%
Net Income Profit after all expenses
$-33.91M
↑ +34.7%
Operating Margin Operating profit as % of sales
-0.9%
↑ +92.4% 14th
FCF / Share Free cash flow per share
$0.00
↑ +105.3%
Long-Term Debt Long-term obligations
$575.75M
— +0.4%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Debt to EquityDebt to Equity is concerning (bottom quartile)
  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
17
Financial Health
22
Cash Quality
21

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters